A-V shunt

A-V shunt

(shŭnt),
References in periodicals archive ?
Namely, high-output congestive heart failure and hepatic encephalopathy suggested the presence of A-V and P-V shunts, respectively, and the presence of an intrahepatic A-V shunt was also indicated by angiography.
Celiac arterial angiography revealed marked dilation, tortuosity and a corkscrewlike appearance of the left hepatic arterial branches, pooling of the contrast medium in the venous phase, and early visualization of the hepatic veins, signifying A-V shunts.
78, suggesting congestive heart failure due to increased venous return through the intrahepatic A-V shunts.
The FDA 510(k) cleared-to- market the Company's Orbital Atherectomy System to remove tissue causing stenosis in synthetic A-V shunts.
Cytograft's technology is targeted at four patient indications: A-V shunts for hemodialysis access, lower limb revascularization for amputation candidates, coronary revascularization for coronary arterial bypass revision candidates and reconstruction of congenital defects in the heart for pediatric patients.
The FDA 510(k) cleared-to-market the Company's Orbital Atherectomy System to remove tissue causing stenosis in synthetic A-V shunts.